Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Carmen van Dooijeweert"'
Autor:
Paul J van Diest, Carmen van Dooijeweert, Nikolas Stathonikos, Tri Q Nguyen, Natalie D ter Hoeve, Rachel N Flach
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Introduction Artificial intelligence (AI) has been on the rise in the field of pathology. Despite promising results in retrospective studies, and several CE-IVD certified algorithms on the market, prospective clinical implementation studies of AI hav
Externí odkaz:
https://doaj.org/article/0bb29f9170b4425fb7cb5defa2d0093e
Autor:
Carmen van Dooijeweert, Paul J. van Diest, Inge O. Baas, Elsken van der Wall, Ivette A. G. Deckers
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background Histologic grade of ductal carcinoma in situ of the breast (DCIS) may become the single biomarker that decides whether patients will be treated. Yet, evidence shows that grading variation in daily practice is substantial. To facil
Externí odkaz:
https://doaj.org/article/0494762ad08c42a19b97c7bbcb7dfc5b
Autor:
Rachel N. Flach, Nina L. Fransen, Andreas F. P. Sonnen, Tri Q. Nguyen, Gerben E. Breimer, Mitko Veta, Nikolas Stathonikos, Carmen van Dooijeweert, Paul J. van Diest
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1042 (2022)
Building on a growing number of pathology labs having a full digital infrastructure for pathology diagnostics, there is a growing interest in implementing artificial intelligence (AI) algorithms for diagnostic purposes. This article provides an overv
Externí odkaz:
https://doaj.org/article/502f2b0a48f846a283879d2656e78a6b
Autor:
Bregje M. Koomen, Mirthe de Boer, Carmen van Dooijeweert, Anne S. R. van Lindert, Ivette A. G. Deckers, Quirinus J. M. Voorham, Stefan M. Willems
Publikováno v:
Virchows Archiv, 707–720. SPRINGER
Programmed death ligand-1 (PD-L1) immunostaining, which aids clinicians in decision-making on immunotherapy for non-small cell lung cancer (NSCLC) patients, is sometimes performed on cytological specimens. In this study, differences in cytology fixat
Autor:
Britt BM Suelmann, Carsten FJ Bakhuis, Carmen van Dooijeweert, Janneke Verloop, Ronald P Zweemer, Sabine C Linn, Elsken van der Wall, Paul J van Diest
Publikováno v:
Cancer Research. 82:P3-12
BACKGROUND Pregnancy-associated breast cancer (PABC), although most commonly defined as breast cancer diagnosed during pregnancy or within one year following delivery, knows a variety of definitions, likely related to the diversity of reported clinic
Autor:
Quirinus J. M. Voorham, Chantal C H J Epskamp-Kuijpers, Bregje M Koomen, Stefan M. Willems, Carmen van Dooijeweert, Ivette A. G. Deckers, Anne S R van Lindert
Publikováno v:
Lung Cancer, 159, 117-126. ELSEVIER IRELAND LTD
Objectives: Immunohistochemical expression of programmed death-ligand 1 (PD-L1) is used as a predictive biomarker for prescription of immunotherapy to non-small cell lung cancer (NSCLC) patients. Accurate assessment of PD-L1 expression is therefore c
Autor:
Elsken van der Wall, Paul J. van Diest, Carmen van Dooijeweert, Carsten F. J. Bakhuis, Sabine C. Linn, Britt B.M. Suelmann
Publikováno v:
Cancer Research. 81:PS7-14
Background: Pregnancy associated breast cancer (PABC) comprises nearly 4% of all breast cancers. Compared to age-matched non-pregnant breast cancer patients, PABC is generally characterized by a particularly aggressive histopathologic profile. Whethe
Autor:
Rachel Flach, Carmen van Dooijeweert, Katja Aben, Britt Suelmann, Peter-Paul Willemse, Paul van Diest, Richard Meijer
Publikováno v:
Journal of Urology. 207
Autor:
Ivette A. G. Deckers, Carmen van Dooijeweert, Inge O. Baas, Paul J. van Diest, Elsken van der Wall
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-9 (2020)
Diagnostic Pathology
Diagnostic Pathology
Background Histologic grade of ductal carcinoma in situ of the breast (DCIS) may become the single biomarker that decides whether patients will be treated. Yet, evidence shows that grading variation in daily practice is substantial. To facilitate qua
Autor:
Inge O. Baas, Carmen van Dooijeweert, Ivette A. G. Deckers, Paul J. van Diest, Elsken van der Wall
Publikováno v:
Journal of Clinical Pathology. 73:793-799
AimsHistological grade is widely used to guide the management of invasive breast cancer (IBC). Yet, substantial interlaboratory and intralaboratory grading variations exist in daily pathology practice. To create awareness and to facilitate quality im